PerpEquities

Equity · Healthcare

Johnson & Johnson (JNJ) perpetual futures

JNJ perpetual futures on 6 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade JNJUSDT.

Johnson & Johnson is a healthcare holding company operating in Innovative Medicine and MedTech segments, developing and selling pharmaceuticals and medical devices.

$258.65-1.0%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · BingX (JNJ-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

6/6 live markets
Venues
6
Live markets
6/6
24h volume
$100.3KCoverage: 4/6 marketsExchange-reported volume: $2.8M
Open interest
$718.5K
Best liquidity
$5M
LBank
Tightest spread
+8.4 bps
Bybit
Highest volume
$53.1K
Bybit
Settlement mix
USDT · 6/6
Perp/spot vol.
0.00x
Spot volume $2.6B
OI / float
0.00%
Float $622.3B
Spot performance
1D-1.02%
5D-5.23%
1M-6.98%
6M+6.25%
YTD+23.72%
1Y+36.07%

Venue matrix

6 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BybitTradeJNJ/USDTTrading$257.70+315.7% APR
+0.288% every 8h
+8.4 bps$14.8K$53.1K$193.5KUSDT25x
OKXTradeJNJ/USDTTrading$258.680.0% APR
0.000% every 8h
+13.0 bps$6.4K$25.9K$178.6KUSDT10x
HTXTradeJNJ/USDTTrading$261.31+11.0% APR
+0.010% every 8h
+95.4 bps$65.4K$17.7K$6.2KUSDT-
Gate.ioTradeJNJ/USDTTrading$258.130.0% APR
0.000% every 8h
+62.3 bps$2.4K$3.6K$231.7KUSDT20x
BingXTradeJNJ-USDTTrading$258.33+5.5% APR
+0.00500% every 8h
+10.7 bps$11.6K$1.6M⚠$2.6KUSDT-
LBankTradeJNJ/USDTTrading$258.650.0% APR
0.000% every 8h
+28.0 bps$5M$1.1M⚠$106KUSDT50x

Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Adequate liquidity · 4 of 6 venues absorb $10k · Typical cost: +50.5 bps – +89.3 bps

Cheapest execution: LBank · +20.4 bps

Too thin: OKX, Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

JNJ

Tightest spread

JNJ

Highest volume

JNJ

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 1h ago
Market cap
$617B
Updated 1h ago
Revenue
$97.9B
Trailing 12 months
Revenue growth
+8%
Next fiscal year
Profit margin
+21.5%
P/E
29.6
Peer P/E 28.1
Free cash flow
$18.7B
Trailing 12 months
More metrics
Net income
$21B
Trailing 12 months
P/S
6.3
Peer P/E
28.1
Similar listed perps
Revenue estimate
$101.3B
Next fiscal year
Earnings
2026-10-13
Revenue est. $25.4B · Updated 1h ago
Dividend
$1.34
2026-08-25

Fundamental detail

Annual + quarterly
Latest revenue$94.2B
Net margin+28.5%
Free cash flow$19.7B
Net debt$28.2B
2020$82.6B
2021$78.7B
2022$80B
2023$85.2B
2024$88.8B
2025$94.2B
PeriodRevenueGrowthNet incomeFCF
2020$82.6B+1%$14.7B$20.2B
2021$78.7B-5%$20.9B$19.8B
2022$80B+2%$17.9B$17.2B
2023$85.2B+6%$35.2B$18.2B
2024$88.8B+4%$14.1B$19.8B
2025$94.2B+6%$26.8B$19.7B
PeriodGross marginOperating marginNet marginROEROA
2020+65.6%+23.9%+17.8%+23.3%+8.4%
2021+70.3%+26.6%+26.5%+28.2%+11.5%
2022+69.3%+26.3%+22.4%+23.4%+9.6%
2023+68.8%+27.5%+41.3%+51.1%+21.0%
2024+69.1%+24.9%+15.8%+19.7%+7.8%
2025+67.9%+27.2%+28.5%+32.9%+13.5%
PeriodCashDebtNet debtCurrent ratio
2020$14B$35.3B$21.3B1.21
2021$14.5B$33.8B$19.3B1.35
2022$12.9B$39.6B$26.8B0.99
2023$21.9B$29.3B$7.5B1.16
2024$24.1B$36.6B$12.5B1.11
2025$19.7B$47.9B$28.2B1.03
PeriodMarket capEnterprise valueP/SP/E
2020$412B$433.3B5.028.0
2021$451B$470.2B5.721.6
2022$461.7B$488.4B5.825.9
2023$397.1B$404.6B4.711.3
2024$345.1B$357.6B3.924.5
2025$504.1B$532.3B5.418.8
Q3 2024$22.5B
Q4 2024$22.5B
Q1 2025$21.9B
Q2 2025$23.7B
Q3 2025$24B
Q4 2025$24.6B
Q1 2026$24.1B
Q2 2026$25.3B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$22.5B+5%$2.7B$5.7B
Q4 2024$22.5B+5%$3.4B$4.8B
Q1 2025$21.9B+2%$11B$3.4B
Q2 2025$23.7B+6%$5.5B$2.5B
Q3 2025$24B+7%$5.2B$8.4B
Q4 2025$24.6B+9%$5.1B$5.5B
Q1 2026$24.1B+10%$5.2B$1.5B
Q2 2026$25.3B+7%$5.5B$3.4B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+69.0%+23.5%+12.0%+3.8%+1.5%
Q4 2024+68.3%+17.1%+15.2%+4.8%+1.9%
Q1 2025+66.4%+28.8%+50.2%+14.1%+5.7%
Q2 2025+67.9%+28.7%+23.3%+7.1%+2.9%
Q3 2025+69.6%+29.6%+21.5%+6.5%+2.7%
Q4 2025+67.6%+22.8%+20.8%+6.3%+2.6%
Q1 2026+66.3%+26.6%+21.8%+6.4%+2.6%
Q2 2026+68.2%+28.3%+21.9%+6.5%+2.8%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$20B$35.8B$15.8B1.03
Q4 2024$24.1B$36.6B$12.5B1.11
Q1 2025$38.5B$52.3B$13.8B1.26
Q2 2025$18.6B$50.8B$32.2B1.01
Q3 2025$18.2B$45.8B$27.6B1.07
Q4 2025$19.7B$47.9B$28.2B1.03
Q1 2026$21.7B$55B$33.3B1.03
Q2 2026$20.4B$49B$28.6B1.09
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$390.1B$405.9B17.436.2
Q4 2024$345B$357.5B15.325.1
Q1 2025$398.9B$412.7B18.29.1
Q2 2025$369.5B$401.7B15.616.7
Q3 2025$441.1B$468.6B18.421.2
Q4 2025$504.1B$532.3B20.524.7
Q1 2026$592.9B$626.2B24.628.3
Q2 2026$630.8B$659.4B24.928.5

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$25.3BQ2 2026
$6.3B$12.7B$19B$25.3BQ3 2023: $21.4BQ4 2023: $21.4BQ1 2024: $21.4BQ2 2024: $22.4BQ3 2024: $22.5BQ4 2024: $22.5BQ1 2025: $21.9BQ2 2025: $23.7BQ3 2025: $24BQ4 2025: $24.6BQ1 2026: $24.1BQ2 2026: $25.3BQ3 2023Q2 2026
Net income$5.5BQ2 2026
$6.5B$13B$19.5B$26BQ3 2023: $26BQ4 2023: $4BQ1 2024: $3.3BQ2 2024: $4.7BQ3 2024: $2.7BQ4 2024: $3.4BQ1 2025: $11BQ2 2025: $5.5BQ3 2025: $5.2BQ4 2025: $5.1BQ1 2026: $5.2BQ2 2026: $5.5BQ3 2023Q2 2026
EBITDA$9BQ2 2026
$3.9B$7.8B$11.7B$15.6BQ3 2023: $7.2BQ4 2023: $6.8BQ1 2024: $5.7BQ2 2024: $7.8BQ3 2024: $5.4BQ4 2024: $5.9BQ1 2025: $15.6BQ2 2025: $8.7BQ3 2025: $9.3BQ4 2025: $7.2BQ1 2026: $8.3BQ2 2026: $9BQ3 2023Q2 2026
Free cash flow$3.4BQ2 2026
$2.1B$4.2B$6.3B$8.4BQ3 2023: $6.5BQ4 2023: $6.3BQ1 2024: $2.9BQ2 2024: $4.7BQ3 2024: $5.7BQ4 2024: $4.8BQ1 2025: $3.4BQ2 2025: $2.5BQ3 2025: $8.4BQ4 2025: $5.5BQ1 2026: $1.5BQ2 2026: $3.4BQ3 2023Q2 2026
EPS$2.27Q2 2026
$2.55$5.11$7.66$10.2Q3 2023: $10.2Q4 2023: $1.67Q1 2024: $1.34Q2 2024: $1.93Q3 2024: $1.11Q4 2024: $1.41Q1 2025: $4.54Q2 2025: $2.29Q3 2025: $2.12Q4 2025: $2.1Q1 2026: $2.14Q2 2026: $2.27Q3 2023Q2 2026
Cash / Debt$20.4BQ2 2026
$13.7B$27.5B$41.2B$55BQ3 2023 · Cash: $19.7BQ3 2023 · Debt: $29.9BQ4 2023 · Cash: $21.9BQ4 2023 · Debt: $29.3BQ1 2024 · Cash: $25.5BQ1 2024 · Debt: $33.6BQ2 2024 · Cash: $24.9BQ2 2024 · Debt: $41.5BQ3 2024 · Cash: $20BQ3 2024 · Debt: $35.8BQ4 2024 · Cash: $24.1BQ4 2024 · Debt: $36.6BQ1 2025 · Cash: $38.5BQ1 2025 · Debt: $52.3BQ2 2025 · Cash: $18.6BQ2 2025 · Debt: $50.8BQ3 2025 · Cash: $18.2BQ3 2025 · Debt: $45.8BQ4 2025 · Cash: $19.7BQ4 2025 · Debt: $47.9BQ1 2026 · Cash: $21.7BQ1 2026 · Debt: $55BQ2 2026 · Cash: $20.4BQ2 2026 · Debt: $49BQ3 2023Q2 2026
CashDebt
Profitability+68.2%Q2 2026
+30.5%+61.0%+91.4%+121.9%Q3 2023 · Gross margin: +69.1%Q4 2023 · Gross margin: +68.2%Q1 2024 · Gross margin: +69.6%Q2 2024 · Gross margin: +69.4%Q3 2024 · Gross margin: +69.0%Q4 2024 · Gross margin: +68.3%Q1 2025 · Gross margin: +66.4%Q2 2025 · Gross margin: +67.9%Q3 2025 · Gross margin: +69.6%Q4 2025 · Gross margin: +67.6%Q1 2026 · Gross margin: +66.3%Q2 2026 · Gross margin: +68.2%Q3 2023 · Operating margin: +29.0%Q4 2023 · Operating margin: +21.5%Q1 2024 · Operating margin: +29.3%Q2 2024 · Operating margin: +29.7%Q3 2024 · Operating margin: +23.5%Q4 2024 · Operating margin: +17.1%Q1 2025 · Operating margin: +28.8%Q2 2025 · Operating margin: +28.7%Q3 2025 · Operating margin: +29.6%Q4 2025 · Operating margin: +22.8%Q1 2026 · Operating margin: +26.6%Q2 2026 · Operating margin: +28.3%Q3 2023 · Net margin: +121.9%Q4 2023 · Net margin: +18.9%Q1 2024 · Net margin: +15.2%Q2 2024 · Net margin: +20.9%Q3 2024 · Net margin: +12.0%Q4 2024 · Net margin: +15.2%Q1 2025 · Net margin: +50.2%Q2 2025 · Net margin: +23.3%Q3 2025 · Net margin: +21.5%Q4 2025 · Net margin: +20.8%Q1 2026 · Net margin: +21.8%Q2 2026 · Net margin: +21.9%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+6.6%Q2 2026
+2.5%+5.0%+7.4%+9.9%Q2 2024: +4.3%Q3 2024: +5.2%Q4 2024: +5.3%Q1 2025: +2.4%Q2 2025: +5.8%Q3 2025: +6.8%Q4 2025: +9.1%Q1 2026: +9.9%Q2 2026: +6.6%Q3 2023Q2 2026
Shares outstanding2.4BQ2 2026
637.4M1.3B1.9B2.5BQ3 2023: 2.5BQ4 2023: 2.4BQ1 2024: 2.4BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4BQ3 2023Q2 2026
Valuation28.5Q2 2026
9.018.127.136.2Q3 2023 · P/E: 3.8Q4 2023 · P/E: 23.3Q1 2024 · P/E: 29.2Q2 2024 · P/E: 18.8Q3 2024 · P/E: 36.2Q4 2024 · P/E: 25.1Q1 2025 · P/E: 9.1Q2 2025 · P/E: 16.7Q3 2025 · P/E: 21.2Q4 2025 · P/E: 24.7Q1 2026 · P/E: 28.3Q2 2026 · P/E: 28.5Q3 2023 · P/S: 18.3Q4 2023 · P/S: 17.6Q1 2024 · P/S: 17.8Q2 2024 · P/S: 15.7Q3 2024 · P/S: 17.4Q4 2024 · P/S: 15.3Q1 2025 · P/S: 18.2Q2 2025 · P/S: 15.6Q3 2025 · P/S: 18.4Q4 2025 · P/S: 20.5Q1 2026 · P/S: 24.6Q2 2026 · P/S: 24.9Q3 2023Q2 2026
P/EP/S
Revenue$94.2B2025
$23.5B$47.1B$70.6B$94.2B2018: $81.6B2019: $82.1B2020: $82.6B2021: $78.7B2022: $80B2023: $85.2B2024: $88.8B2025: $94.2B20182025
Net income$26.8B2025
$8.8B$17.6B$26.4B$35.2B2018: $15.3B2019: $15.1B2020: $14.7B2021: $20.9B2022: $17.9B2023: $35.2B2024: $14.1B2025: $26.8B20182025
EBITDA$41.1B2025
$10.3B$20.5B$30.8B$41.1B2018: $25.9B2019: $24.7B2020: $23.9B2021: $26.8B2022: $26.6B2023: $23.3B2024: $24.8B2025: $41.1B20182025
Free cash flow$19.7B2025
$5B$10.1B$15.1B$20.2B2018: $18.5B2019: $19.9B2020: $20.2B2021: $19.8B2022: $17.2B2023: $18.2B2024: $19.8B2025: $19.7B20182025
EPS$112025
$3.43$6.86$10.3$13.72018: $5.612019: $5.632020: $5.512021: $7.812022: $6.732023: $13.72024: $5.792025: $1120182025
Cash / Debt$19.7B2025
$12B$24B$35.9B$47.9B2018 · Cash: $18.1B2018 · Debt: $30.5B2019 · Cash: $17.3B2019 · Debt: $27.7B2020 · Cash: $14B2020 · Debt: $35.3B2021 · Cash: $14.5B2021 · Debt: $33.8B2022 · Cash: $12.9B2022 · Debt: $39.6B2023 · Cash: $21.9B2023 · Debt: $29.3B2024 · Cash: $24.1B2024 · Debt: $36.6B2025 · Cash: $19.7B2025 · Debt: $47.9B20182025
CashDebt
Profitability+67.9%2025
+17.6%+35.1%+52.7%+70.3%2018 · Gross margin: +66.8%2019 · Gross margin: +66.4%2020 · Gross margin: +65.6%2021 · Gross margin: +70.3%2022 · Gross margin: +69.3%2023 · Gross margin: +68.8%2024 · Gross margin: +69.1%2025 · Gross margin: +67.9%2018 · Operating margin: +26.0%2019 · Operating margin: +25.6%2020 · Operating margin: +23.9%2021 · Operating margin: +26.6%2022 · Operating margin: +26.3%2023 · Operating margin: +27.5%2024 · Operating margin: +24.9%2025 · Operating margin: +27.2%2018 · Net margin: +18.8%2019 · Net margin: +18.4%2020 · Net margin: +17.8%2021 · Net margin: +26.5%2022 · Net margin: +22.4%2023 · Net margin: +41.3%2024 · Net margin: +15.8%2025 · Net margin: +28.5%20182025
Gross marginOperating marginNet margin
Revenue growth+6.0%2025
-1.9%+0.9%+3.7%+6.5%2019: +0.6%2020: +0.6%2021: -4.7%2022: +1.6%2023: +6.5%2024: +4.3%2025: +6.0%20182025
Shares outstanding2.4B2025
682.2M1.4B2B2.7B2018: 2.7B2019: 2.7B2020: 2.7B2021: 2.7B2022: 2.7B2023: 2.6B2024: 2.4B2025: 2.4B20182025
Valuation18.82025
7.014.021.028.02018 · P/E: 22.42019 · P/E: 25.42020 · P/E: 28.02021 · P/E: 21.62022 · P/E: 25.92023 · P/E: 11.32024 · P/E: 24.52025 · P/E: 18.82018 · P/S: 4.22019 · P/S: 4.72020 · P/S: 5.02021 · P/S: 5.72022 · P/S: 5.82023 · P/S: 4.72024 · P/S: 3.92025 · P/S: 5.420182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-13
Revenue est. $25.4B · Updated 1h ago
Dividend
$1.34
2026-08-25

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202611.44$101.3B+8%6
FY 202712.56$108.8B+15%6
FY 202814.28$117.4B+25%1
FY 202916.17$125.4B+33%1
FY 203018.05$134.9B+43%1
Q1 20272.89$25.7B+7%4

Company events

6
2026-10-13Earnings · Before market openActual - / Estimate 2.78-
2026-08-25Dividend$1.34-
2026-07-15EarningsActual 2.9 / Estimate 2.84Beat
2026-05-26Dividend$1.34-
2026-04-14EarningsActual 2.7 / Estimate 2.68Beat
2026-02-24Dividend$1.3-

Peer comparison

Similar listed perps

FMP company data

Company intelligence

Updated: Oct 4, 2026, 11:10 PM UTC

Company profile

Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Joaquin Duato
Employees
141,700
IPO date
Jan 2, 1962
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei5.33
Piotroski scorei8/9
FMP ratingiB+
Owner earningsi$3.75B$1.54 per share
ESG risk ratingiB+Industry rank: 3 out of 28

Rating factors

Return on equityi
5
Return on assetsi
5
Debt to equityi
1
Price to earningsi
2
Price to booki
1
Market cap history
$624.74B-1.5%Jul 26 – Oct 26
$607.16B$636.70B$666.24BHigh: $666.24B · 2026-08-24Low: $607.16B · 2026-07-20Latest: $624.74B · 2026-10-02Jul 26Aug 26Sep 26Oct 26
Latest: $624.74B · 2026-10-02High: $666.24B · 2026-08-24Low: $607.16B · 2026-07-20
Largest fund holders
FundWeightShares held
VTI0.87%76.5M
VOO0.97%64M
IVV0.99%32.1M
1657.T0.76%32.1M
XAW.TO0.58%32.1M
XUU.TO0.88%32.1M
XWD.TO0.71%32.1M
FXAIX0.96%29.8M
1557.T0.98%29.7M
SPY0.94%29.5M
VTV2.33%23M
XLV10.32%17.1M

Analyst track record

How the analysts covering JNJ have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings177490
Analysts2834
Buy / hold / sell125 / 52 / 0282 / 207 / 1
Upgrades / downgrades / initiations4 / 0 / 28 / 3 / 6
Price targets hit / missed88 / 80 (52%)371 / 80 (82%)
Avg. return after a rating (TipRanks)+5.8%+32.1%
Best / worst call+47.0% / -19.2%+72.4% / -19.2%

After buy calls on this stock: median 21-day move +1.2% vs S&P 500 -1.2% (n = 280)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Asad HaiderGoldman Sachs100% hit rate on this stock · 8 targets measuredBuytarget $282Aug 25, 2026
  2. Josh JenningsTD Cowen48% hit rate on this stock · 21 targets measuredBuytarget $250Apr 23, 2026
  3. Shagun Singh ChadhaRBC Capital46% hit rate on this stock · 35 targets measuredBuytarget $287Jul 13, 2026

Latest ratings

DateAnalystCallTarget
Oct 2, 2026Larry BiegelsenWells FargoBuyReiterated$282
Sep 29, 2026Chris SchottJ.P. MorganHoldMaintained$285
Sep 29, 2026Chris SchottJ.P. MorganHoldMaintained$285
Sep 29, 2026Jason GerberryBank of America SecuritiesHoldReiterated$278
Sep 28, 2026Louise ChenScotiabankBuyMaintained$305
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$220$240$260$280Nov 25 · Buy 14 · Hold 7 · Sell 0Nov 25Dec 25 · Buy 14 · Hold 8 · Sell 0Jan 26 · Buy 14 · Hold 7 · Sell 0Jan 26Feb 26 · Buy 14 · Hold 8 · Sell 0Mar 26 · Buy 14 · Hold 8 · Sell 0Mar 26Apr 26 · Buy 12 · Hold 6 · Sell 0May 26 · Buy 13 · Hold 6 · Sell 0May 26Jun 26 · Buy 13 · Hold 6 · Sell 0Jul 26 · Buy 18 · Hold 6 · Sell 0Jul 26Aug 26 · Buy 18 · Hold 5 · Sell 0Sep 26 · Buy 18 · Hold 6 · Sell 0Sep 26Oct 26 · Buy 18 · Hold 6 · Sell 0Nov 25 · avg. target $207Dec 25 · avg. target $217Jan 26 · avg. target $229Feb 26 · avg. target $231Mar 26 · avg. target $242Apr 26 · avg. target $264May 26 · avg. target $264Jun 26 · avg. target $264Jul 26 · avg. target $278Aug 26 · avg. target $281Sep 26 · avg. target $286Oct 26 · avg. target $286Nov 25 · month-end close $207Dec 25 · month-end close $207Jan 26 · month-end close $227Feb 26 · month-end close $248Mar 26 · month-end close $244Apr 26 · month-end close $230May 26 · month-end close $225Jun 26 · month-end close $254Jul 26 · month-end close $256Aug 26 · month-end close $266Sep 26 · month-end close $265Oct 26 · month-end close $256

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 2, 2026 · 177 ratings

Frequently asked questions

Where can I trade JNJ perpetual futures?

Johnson & Johnson (JNJ) perpetual futures trade on 6 crypto venues, including BingX, LBank, Bybit. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade JNJ around the clock?

Yes. Unlike the underlying stock, JNJ perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on JNJ perpetuals?

Right now the JNJ perp funding rate is +2.7% annualized (venue median), ranging from 0.0% to +315.7% across 6 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the JNJ perp price compare to the Johnson & Johnson stock?

The venue-median JNJ perp mark is $258.5 versus a reference stock price of $258.7, a basis of -0.1%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a JNJ perpetual future?

A JNJ perpetual is a derivative that tracks the price of Johnson & Johnson with no expiry date. It lets you take long or short exposure to Johnson & Johnson on crypto venues, around the clock.

What is JNJUSDT perpetual?

JNJUSDT is the symbol most crypto exchanges use for the Johnson & Johnson perpetual settled in USDT (Tether). It tracks the JNJ share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

JNJ perpetuals · perpequities.comJNJ perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/jnj-perp"><img src="https://perpequities.com/badge/jnj-perp.svg" width="240" height="64" alt="JNJ perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of JNJ perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for JNJ — one email every Sunday.

Watchlist and alerts

Price and funding alerts for JNJ, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X